Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin

Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin

Abstract Background Postthrombotic syndrome (PTS) is a long‐term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood but inadequate anticoagulant therapy with vitamin K antagonists is a known risk factor for the development of PTS....

Full description

Bibliographic Details
Main Authors: Ingrid M. Bistervels, Roisin Bavalia, Jan Beyer‐Westendorf, Arina J. tenCate‐Hoek, Sebastian M. Schellong, Michael J. Kovacs, Nicolas Falvo, Karina Meijer, Dominique Stephan, Wim G. Boersma, Marije tenWolde, Francis Couturaud, Peter Verhamme, Dominique Brisot, Susan R. Kahn, Waleed Ghanima, Karine Montaclair, Amanda Hugman, Patrick Carroll, Gilles Pernod, Olivier Sanchez, Emile Ferrari, Pierre‐Marie Roy, Marie‐Antoinette Sevestre‐Pietri, Simone Birocchi, Hilde S. Wik, Barbara A. Hutten, Michiel Coppens, Christiane Naue, Michael A. Grosso, Minggao Shi, Yong Lin, Isabelle Quéré, Saskia Middeldorp, the Hokusai PTS Investigators
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
edoxaban
postthrombotic syndrome
quality of life
venous thrombosis
warfarin
Online Access:https://doi.org/10.1002/rth2.12748

Internet

https://doi.org/10.1002/rth2.12748

Similar Items